Virtual Meeting
17:00 – 17:05
Invitation and introduction prof. dr hab. n. med. Renata Duchnowska
5 min
17:05 – 17:20
Learning from Real Life: Polish RWE Experience with CDK4/6 Inhibitors prof. dr hab. n. med. Renata Duchnowska
15 min
17:20 – 17:35
Learning from Real Life: Israeli RWE Experience with CDK4/6 Inhibitors prof. Nava Siegelmann-Danieli
15 min
17:35 – 17:50
Learning from Real Life: Romanian RWE Experience with CDK4/6 Inhibitors Dr. Cristian Lungulescu
15 min
17:50 – 17:55
Discussion
5 min
17:55 – 18:20
Beyond Clinical Trials: The Role of Real‑World Evidence in Contemporary Breast Cancer Care dr n. med. Michał Bieńkowski
25 min
18:20 – 18:25
Discussion
5 min
18:25 – 18:30
Closing prof. dr hab. n. med. Renata Duchnowska
5 min

Pfizer Polska Sp. z o.o. ul. Żwirki i Wigury 16 B, 02-092 Warszawa Kapitał zakładowy 33.860.000 zł KRS 0000022310 Sąd Rejonowy dla m.st. Warszawy, NIP 5213115586 BDO 000189470 tel. +48 (22) 335 61 00.

EM-POL-plb-0049

Download program as PDF
Copyrights © 2026 Via Medica